nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledgment of Reviewers 2008
|
|
|
2009 |
27 |
1 |
p. 115- 1 p. |
artikel |
2 |
Active surveillance of renal masses in elderly patients
|
Crispen, Paul L. |
|
2009 |
27 |
1 |
p. 107- 1 p. |
artikel |
3 |
Adjuvant intraoperative electron radiotherapy and external beam radiotherapy for locally advanced transitional cell carcinoma of the ureter
|
Zhang, Qing |
|
2009 |
27 |
1 |
p. 14-20 7 p. |
artikel |
4 |
2007 Annual meeting of the Society of Urologic Oncology and the Society of Basic Urologic Research: Introduction
|
Mohler, James L. |
|
2009 |
27 |
1 |
p. 34-35 2 p. |
artikel |
5 |
Are we underutilizing minimally invasive approaches for upper tract urothelial carcinoma?
|
Wolf Jr., J. Stuart |
|
2009 |
27 |
1 |
p. 75-80 6 p. |
artikel |
6 |
BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo
|
Li, Yingming |
|
2009 |
27 |
1 |
p. 112-113 2 p. |
artikel |
7 |
Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP-12 dependent manner
|
Li, Yingming |
|
2009 |
27 |
1 |
p. 113-114 2 p. |
artikel |
8 |
Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma
|
Russo, Paul |
|
2009 |
27 |
1 |
p. 103-104 2 p. |
artikel |
9 |
Clinical correlates of renal angiomyolipoma subtypes in 209 patients: Classic, fat poor, tuberous sclerosis associated, and epithelioid
|
Crispen, Paul L. |
|
2009 |
27 |
1 |
p. 105-106 2 p. |
artikel |
10 |
Contents
|
|
|
2009 |
27 |
1 |
p. ii-iv nvt p. |
artikel |
11 |
Dendritic cells transduced with a PSMA-encoding adenovirus and cocultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against prostate cancer cells
|
Wang, Kebing |
|
2009 |
27 |
1 |
p. 26-32 7 p. |
artikel |
12 |
Depsipeptide (FK228) inhibits growth of human prostate cancer cells
|
Koeneman, Kenneth S. |
|
2009 |
27 |
1 |
p. 114- 1 p. |
artikel |
13 |
Editorial Board
|
|
|
2009 |
27 |
1 |
p. i- 1 p. |
artikel |
14 |
Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA)
|
Loeb, Stacy |
|
2009 |
27 |
1 |
p. 64-66 3 p. |
artikel |
15 |
Feasibility and outcomes of repeat partial nephrectomy
|
Russo, Paul |
|
2009 |
27 |
1 |
p. 103- 1 p. |
artikel |
16 |
Information for Authors
|
|
|
2009 |
27 |
1 |
p. IBC- 1 p. |
artikel |
17 |
In memoriam: A curious and careful gentleman— John P. Donohue, M.D
|
Koch, Michael |
|
2009 |
27 |
1 |
p. 1-2 2 p. |
artikel |
18 |
Insulin-like growth factor-I dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells
|
Li, Yingming |
|
2009 |
27 |
1 |
p. 112- 1 p. |
artikel |
19 |
Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases
|
Koeneman, Kenneth S. |
|
2009 |
27 |
1 |
p. 110- 1 p. |
artikel |
20 |
Masthead
|
|
|
2009 |
27 |
1 |
p. IFC- 1 p. |
artikel |
21 |
Mechanisms mediating androgen receptor reactivation after castration
|
Yuan, Xin |
|
2009 |
27 |
1 |
p. 36-41 6 p. |
artikel |
22 |
Oncogenic activation of androgen receptor
|
Kung, Hsing-Jien |
|
2009 |
27 |
1 |
p. 48-52 5 p. |
artikel |
23 |
Optimal timing of chemotherapy in androgen independent prostate cancer
|
Schnadig, Ian D. |
|
2009 |
27 |
1 |
p. 97-100 4 p. |
artikel |
24 |
Optimizing outcomes at every stage of bladder cancer: Do we practice it?
|
Herr, Harry |
|
2009 |
27 |
1 |
p. 72-74 3 p. |
artikel |
25 |
Outcomes for intermediate risk prostate cancer: Are there advantages for surgery, external radiation, or brachytherapy?
|
Klein, Eric A. |
|
2009 |
27 |
1 |
p. 67-71 5 p. |
artikel |
26 |
Phase 2 study of granulocyte-macrophage colony-stimulating factor plus thalidomide in patients with hormone-naïve adenocarcinoma of the prostate
|
Amato, Robert J. |
|
2009 |
27 |
1 |
p. 8-13 6 p. |
artikel |
27 |
Positive surgical margins: The argument for androgen deprivation and chemotherapy
|
Higano, Celestia S. |
|
2009 |
27 |
1 |
p. 89-91 3 p. |
artikel |
28 |
Post-radical prostatectomy management options for positive surgical margins: Argument for observation
|
Moul, Judd W. |
|
2009 |
27 |
1 |
p. 92-96 5 p. |
artikel |
29 |
Post–radical prostatectomy management options for the positive surgical margin: Argument for adjuvant radiotherapy
|
Chin, Joseph L. |
|
2009 |
27 |
1 |
p. 87-88 2 p. |
artikel |
30 |
Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms
|
Koeneman, Kenneth S. |
|
2009 |
27 |
1 |
p. 110- 1 p. |
artikel |
31 |
Radical nephrectomy with and without lymph node dissection: Final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881
|
Russo, Paul |
|
2009 |
27 |
1 |
p. 102- 1 p. |
artikel |
32 |
Receptor activator of NF-κB ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells
|
Koeneman, Kenneth S. |
|
2009 |
27 |
1 |
p. 111-112 2 p. |
artikel |
33 |
Role of Wnts in prostate cancer bone metastases
|
Koeneman, Kenneth S. |
|
2009 |
27 |
1 |
p. 111- 1 p. |
artikel |
34 |
R-spondin2 is a secreted activator of Wnt/β-catenin signaling and is required for Xenopus myogenesis
|
Koeneman, Kenneth S. |
|
2009 |
27 |
1 |
p. 111- 1 p. |
artikel |
35 |
Secreted frizzled related protein 1 is a paracrine modulator of epithelial branching morphogenesis, proliferation, and secretory gene expression in the prostate
|
Koeneman, Kenneth S. |
|
2009 |
27 |
1 |
p. 109- 1 p. |
artikel |
36 |
1. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer
|
Blute, Michael L. |
|
2009 |
27 |
1 |
p. 107-108 2 p. |
artikel |
37 |
SUO/SBUR 2007 Annual meeting proceedings: Overview
|
Evans, Christopher P. |
|
2009 |
27 |
1 |
p. 33- 1 p. |
artikel |
38 |
Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma
|
Blute, Michael L. |
|
2009 |
27 |
1 |
p. 108-109 2 p. |
artikel |
39 |
Survey Section Editorial Board
|
|
|
2009 |
27 |
1 |
p. 101- 1 p. |
artikel |
40 |
The Coffey Lecture: Steroidogenic enzyme inhibitors and hormone dependent cancer
|
Brodie, Angela |
|
2009 |
27 |
1 |
p. 53-63 11 p. |
artikel |
41 |
The continued debate: Intermittent vs. continuous hormonal ablation for metastatic prostate cancer
|
Gleave, Martin |
|
2009 |
27 |
1 |
p. 81-86 6 p. |
artikel |
42 |
The impact of variant histology on the outcome of bladder cancer treated with curative intent
|
Black, Peter C. |
|
2009 |
27 |
1 |
p. 3-7 5 p. |
artikel |
43 |
The Ral GTPase pathway in metastatic bladder cancer: Key mediator and therapeutic target
|
Smith, Steven Christopher |
|
2009 |
27 |
1 |
p. 42-47 6 p. |
artikel |
44 |
The screening for occult renal disease (SCORED) value is associated with a higher risk for having or developing chronic kidney disease in patients treated for small renal masses
|
Russo, Paul |
|
2009 |
27 |
1 |
p. 105- 1 p. |
artikel |
45 |
The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses
|
Crispen, Paul L. |
|
2009 |
27 |
1 |
p. 106-107 2 p. |
artikel |
46 |
Tissue-marking scheme for a cost-effective extended prostate biopsy protocol
|
Firoozi, Farzeen |
|
2009 |
27 |
1 |
p. 21-25 5 p. |
artikel |
47 |
Waiting time from initial urological consultation to nephrectomy for renal cell carcinoma—does it affect survival?
|
Russo, Paul |
|
2009 |
27 |
1 |
p. 104- 1 p. |
artikel |